Cargando…
Nucleostemin expression in invasive breast cancer
BACKGROUND: Recently, the cancer stem cell hypothesis has become widely accepted. Cancer stem cells are thought to possess the ability to undergo self-renewal and differentiation, similar to normal stem cells. Nucleostemin (NS), initially cloned from rat neural stem cells, binds to various proteins,...
Autores principales: | Kobayashi, Takayuki, Masutomi, Kenkichi, Tamura, Kenji, Moriya, Tomoyuki, Yamasaki, Tamio, Fujiwara, Yasuhiro, Takahashi, Shunji, Yamamoto, Junji, Tsuda, Hitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994431/ https://www.ncbi.nlm.nih.gov/pubmed/24650343 http://dx.doi.org/10.1186/1471-2407-14-215 |
Ejemplares similares
-
A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer
por: Kobayashi, Takayuki, et al.
Publicado: (2013) -
Utility of (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging for Prediction of Metastasis to Sentinel and Nonsentinel Nodes in Patients with Clinically Node-Negative Breast Cancer
por: Yamagishi, Yoji, et al.
Publicado: (2020) -
Nucleostemin: New Stabilizer of ARF
por: Cao, Bo, et al.
Publicado: (2015) -
Pathological features of triple‐negative breast cancers that showed progressive disease during neoadjuvant chemotherapy
por: Tanabe, Yuko, et al.
Publicado: (2017) -
Metachronous bilateral triple-negative breast cancer associated with neurofibromatosis type 1: A case report
por: Yamagishi, Yoji, et al.
Publicado: (2019)